Breaking News, Collaborations & Alliances

BioVaxys Joins the Rapid Response Partnership Vehicle

Will support the US Government's BARDA in its objective to accelerate Medical Countermeasure product and technology development.

Author Image

By: Charlie Sternberg

Associate Editor

BioVaxys Technology Corp. has joined The Rapid Response Partnership Vehicle (RRPV), a consortium of biopharma, contractors, government agencies, and research institutions that support the US Government’s Biomedical Advanced Research and Development Authority (BARDA) in its objective to accelerate Medical Countermeasure product and technology development to address evolving needs including pandemic influenza, emerging infectious diseases, and other biological threats.   The RRPV is a mult...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters